https://commons.ufh.ac.za/vital/access/manager/Index en-us 5 An in-silico study of the type II NADH: Quinone Oxidoreductase (ndh2). A new anti-malaria drug target https://commons.ufh.ac.za/vital/access/manager/Repository/vital:65767 Wed 26 Jul 2023 09:09:34 SAST ]]> In silico study of Plasmodium 1-deoxy-dxylulose 5-phosphate reductoisomerase (DXR) for identification of novel inhibitors from SANCDB https://commons.ufh.ac.za/vital/access/manager/Repository/vital:28523 Thu 13 May 2021 07:20:26 SAST ]]>